Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Healthcare Market Research Reports

Titlepublishedprice

United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2014

By Business Monitor International
"......rnment will gradually contribute less to the country's healthcare spending. Between 2013 and 2018, we expect private sector healthcare spending to outpace public. However, the public sector will remain the main source of healthcare expenditure, contr......"
23-Jul-2014$1295

Czech Republic Pharmaceuticals and Healthcare Report Q3 2014

By Business Monitor International
"......alition government poses downside risk to our forecasts given its commitment to containing healthcare costs and improving access to medicines. Despite these concerns, our view is more optimistic over the long term. We believe that the need for innova......"
23-Jul-2014$1295

Denmark Pharmaceuticals and Healthcare Report Q3 2014

By Business Monitor International
"...... will see the Danish government continue to adapt strategies and cost-containment measures to manage increasing healthcare costs. Despite this, we believe the country's high per-capita drug expenditure, stable and transparent operating environment, a......"
23-Jul-2014$1295

Iraq Pharmaceuticals and Healthcare Report Q3 2014

By Business Monitor International
"......worth USD276mn. In addition, new restrictions aim to end the chaos in which materials have entered the country in previous years, targeting control over drug policy and ensuring the supply of medicines in adequate quantities and at reasonable prices......."
23-Jul-2014$1295

Kuwait Pharmaceuticals and Healthcare Report Q3 2014

By Business Monitor International
"......fake generic drugs presents opportunities for the segment in the country, and has spurred partnership agreements with local distributors in the region. Healthcare spending will remain strained as the government continues to legislate populist measure......"
23-Jul-2014$1295

Malaysia Pharmaceuticals and Healthcare Report Q3 2014

By Business Monitor International
"......e in 2013. The country's slower economic growth in 2014, coupled with the fact that investment in the pharmaceuticals sector will take longer than expected to bring returns, are downside risks to our outlook. Headline Expenditure Projections ? Pharma......"
23-Jul-2014$1295

Portugal Pharmaceuticals and Healthcare Report Q3 2014

By Business Monitor International
"......s is because while Portugal exited its bailout programme in May 2014 without the need for a new financial package, government austerity measures are likely to curb pharmaceutical reimbursement. Portuguese public hospitals are unable to reduce their d......"
23-Jul-2014$1295

Qatar Pharmaceuticals and Healthcare Report Q3 2014

By Business Monitor International
"......among GCC member states will reduce medicine prices in Qatar and improve its national drug accessibility, if implemented properly. Although the drug pricing controls can potentially negatively affect multinationals' revenues in the country, increasin......"
23-Jul-2014$1295

South Africa Pharmaceuticals and Healthcare Report Q3 2014

By Business Monitor International
"......01bn (USD3.52bn) in 2013 to ZAR37.53bn (USD3.51bn) in 2014; +10.3% in local currency terms and -0.5% in US dollar terms. Forecast broadly in line with Q114. ? Healthcare: ZAR301.49bn (USD31.24bn) in 2013 to ZAR327.69bn (USD30.62n) in 2014; +8.7% in l......"
23-Jul-2014$1295

Sri Lanka Pharmaceuticals and Healthcare Report Q3 2014

By Business Monitor International
"......are sector growth will outpace economic growth over the five-year forecast period. Improved relations with India, after the country abstained from voting on the UNHCR resolution, are likely to spur further investments from Indian hospital groups such......"
23-Jul-2014$1295
Live Chat
Live Chat by Comm100